These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30545834)

  • 1. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
    Thakar MS; Broglie L; Logan B; Artz A; Bunin N; Burroughs LM; Fretham C; Jacobsohn DA; Loren AW; Kurtzberg J; Martinez CA; Mineishi S; Nelson AS; Woolfrey A; Pasquini MC; Sorror ML
    Blood; 2019 Feb; 133(7):754-762. PubMed ID: 30545834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
    Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
    Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
    JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.
    Nelson AS; Vajdic CM; Ashton LJ; Le Marsney RE; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
    Pediatr Blood Cancer; 2017 Jan; 64(1):197-202. PubMed ID: 27671369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies.
    Chaudhri NA; Aljurf M; Almohareb FI; Alzahrani HA; Bashir Q; Savani B; Gupta V; Hashmi SK
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):173-177. PubMed ID: 28692818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
    Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
    Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
    Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.
    Sorror ML; Logan BR; Zhu X; Rizzo JD; Cooke KR; McCarthy PL; Ho VT; Horowitz MM; Pasquini MC
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1479-87. PubMed ID: 25862591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
    Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].
    Kállay K; Csomor J; Ádám E; Bödör C; Kassa C; Simon R; Kovács G; Péter G; Ottóffy G; Bartyik K; Kiss C; Masát P; Réti M; Tóth B; Kriván G
    Orv Hetil; 2018 Oct; 159(42):1710-1719. PubMed ID: 30334483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
    Majhail NS; Brunstein CG; McAvoy S; DeFor TE; Al-Hazzouri A; Setubal D; Arora M; Le CT; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):985-992. PubMed ID: 18721761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cell transplantation for nonmalignant disorders.
    Tolar J; Mehta PA; Walters MC
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S166-71. PubMed ID: 22226101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
    Li Q; Luo C; Luo C; Wang J; Li B; Ding L; Chen J
    Ann Hematol; 2017 Aug; 96(8):1389-1397. PubMed ID: 28623394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
    Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
    Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients.
    Cheng G; Smith MA; Phelan R; Brazauskas R; Strom J; Ahn KW; Hamilton B; Peterson A; Savani B; Schoemans H; Schoettler M; Sorror M; Higham C; Kharbanda S; Dvorak CC; Zinter MS
    Transplant Cell Ther; 2024 Oct; 30(10):1017.e1-1017.e12. PubMed ID: 39089527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience.
    Aljasem HA; Messner HA; Lipton JH; Kim DDH; Viswabandya A; Thyagu S; Deotare U; Michelis FV
    Eur J Haematol; 2018 Mar; 100(3):308-314. PubMed ID: 29240253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases.
    Broglie L; Friend BD; Chhabra S; Logan BR; Bupp C; Schiller G; Savani BN; Stadtmauer E; Abraham AA; Aljurf M; Badawy SM; Perez MAD; Guinan EC; Hashem H; Krem MM; Lazarus HM; Rotz SJ; Wirk B; Yared JA; Pasquini M; Thakar MS; Sorror ML
    Transplant Cell Ther; 2023 Feb; 29(2):125.e1-125.e9. PubMed ID: 36442768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.